Arai J, Okumura A, Kimoto S, Sakamoto K, Kitada T, Kitano R
Hepatol Int. 2025; .
PMID: 40085416
DOI: 10.1007/s12072-025-10800-y.
Yi E, Lee E, Park H, Lee H, Yun S, Kim H
J Exp Clin Cancer Res. 2025; 44(1):86.
PMID: 40045373
PMC: 11884141.
DOI: 10.1186/s13046-025-03351-5.
Alles M, Demberg T, Liyanage N
Curr Opin HIV AIDS. 2025; 20(2):145-153.
PMID: 39774039
PMC: 11802316.
DOI: 10.1097/COH.0000000000000913.
Imam M, Kianian A, Bhat S, Fure Lukes V, Greiner-Tollersrud L, Edholm E
Front Immunol. 2025; 15:1463345.
PMID: 39759529
PMC: 11695323.
DOI: 10.3389/fimmu.2024.1463345.
Ming R, Wu H, Wu Z
Sci Rep. 2024; 14(1):25644.
PMID: 39463412
PMC: 11514233.
DOI: 10.1038/s41598-024-77105-2.
Dihydrotestosterone Enhances MICA-Mediated Immune Responses to Epstein-Barr Virus-Associated Gastric Carcinoma.
Seo D, Byun H, Cho M, Lee S, Youn S, Lee J
Cancers (Basel). 2024; 16(18).
PMID: 39335190
PMC: 11429822.
DOI: 10.3390/cancers16183219.
Chromosomal-level reference genome assembly of muskox (Ovibos moschatus) from Banks Island in the Canadian Arctic, a resource for conservation genomics.
Lok S, Lau T, Trost B, Tong A, Paton T, Wintle R
Sci Rep. 2024; 14(1):21023.
PMID: 39284808
PMC: 11405533.
DOI: 10.1038/s41598-024-67270-9.
Isolation of anti-tumor monoclonal antibodies targeting on MICA/B α3 domain by single B cell technology for colon cancer therapy.
Tang X, He L, Wang X, Liu S, Liu X, Shen X
Heliyon. 2024; 10(15):e35697.
PMID: 39170144
PMC: 11336886.
DOI: 10.1016/j.heliyon.2024.e35697.
A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review).
Huang S, Qin Z, Wang F, Kang Y, Ren B
Oncol Rep. 2024; 52(4).
PMID: 39155864
PMC: 11358674.
DOI: 10.3892/or.2024.8796.
Epigenetic regulation of major histocompatibility complexes in gastrointestinal malignancies and the potential for clinical interception.
Tovar Perez J, Zhang S, Hodgeman W, Kapoor S, Rajendran P, Kobayashi K
Clin Epigenetics. 2024; 16(1):83.
PMID: 38915093
PMC: 11197381.
DOI: 10.1186/s13148-024-01698-8.
Natural killer cells in cancer immunotherapy.
Wang D, Dou L, Sui L, Xue Y, Xu S
MedComm (2020). 2024; 5(7):e626.
PMID: 38882209
PMC: 11179524.
DOI: 10.1002/mco2.626.
Nanobody-based CAR NK cells for possible immunotherapy of MICA tumors.
Verhaar E, van Keizerswaard W, Knoflook A, Balligand T, Ploegh H
PNAS Nexus. 2024; 3(5):pgae184.
PMID: 38756234
PMC: 11096969.
DOI: 10.1093/pnasnexus/pgae184.
Targeting senescent cells with NKG2D-CAR T cells.
Deng Y, Kumar A, Xie K, Schaaf K, Scifo E, Morsy S
Cell Death Discov. 2024; 10(1):217.
PMID: 38704364
PMC: 11069534.
DOI: 10.1038/s41420-024-01976-7.
Transcriptome-wide association studies associated with Crohn's disease: challenges and perspectives.
Jia K, Shen J
Cell Biosci. 2024; 14(1):29.
PMID: 38403629
PMC: 10895848.
DOI: 10.1186/s13578-024-01204-w.
Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in infection.
Anthofer M, Windisch M, Haller R, Ehmann S, Wrighton S, Miller M
Front Immunol. 2024; 15:1282680.
PMID: 38318189
PMC: 10839011.
DOI: 10.3389/fimmu.2024.1282680.
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma.
Yoon S, Park S, Cho J, Ryu K, Yandava B, Lee S
Front Oncol. 2023; 13:1194315.
PMID: 38033491
PMC: 10687412.
DOI: 10.3389/fonc.2023.1194315.
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer.
Tan G, Spillane K, Maher J
Biology (Basel). 2023; 12(8).
PMID: 37626965
PMC: 10452210.
DOI: 10.3390/biology12081079.
Impact of NKG2D Signaling on Natural Killer and T-Cell Function in Cerebral Ischemia.
David C, Ruck T, Rolfes L, Mencl S, Kraft P, Schuhmann M
J Am Heart Assoc. 2023; 12(12):e029529.
PMID: 37301761
PMC: 10356034.
DOI: 10.1161/JAHA.122.029529.
Tumor-Infiltrating CD45RO Memory Cells Are Associated with Favorable Prognosis in Oral Squamous Cell Carcinoma Patients.
Ito N, Yamasaki S, Shintani T, Matsui K, Obayashi F, Koizumi K
Cancers (Basel). 2023; 15(8).
PMID: 37190149
PMC: 10136989.
DOI: 10.3390/cancers15082221.
A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors.
Goulding J, Yeh W, Hancock B, Blum R, Xu T, Yang B
Med. 2023; 4(7):457-477.e8.
PMID: 37172578
PMC: 10524375.
DOI: 10.1016/j.medj.2023.04.004.